Dual porphyria with mutations in both the UROD and HMBS genes

Annals of Clinical Biochemistry

Volumn 43, Issue 1, 2006, Pages 80-82

  Harraway, James R ^a   Florkowski, Christopher M ^a   Sies, Christiaan ^a   George, Peter M ^a  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

PORPHOBILINOGEN; PORPHOBILINOGEN DEAMINASE; UROPORPHYRINOGEN DECARBOXYLASE;

ACUTE INTERMITTENT PORPHYRIA; ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); FECES ANALYSIS; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; PORPHYRIA; PORPHYRIA CUTANEA TARDA; PORPHYRIA VARIEGATA; PRIORITY JOURNAL; RASH; URINALYSIS;

ADULT; BASE SEQUENCE; FEMALE; HUMANS; HYDROXYMETHYLBILANE SYNTHASE; MUTATION; PORPHYRIAS; UROPORPHYRINOGEN DECARBOXYLASE;

EID: 30844438513     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456306775141641     Document Type: Article

References (18)

1. Kappas A, Shigeru S, Galbraith RA, Nordmann Y. The Porphyrias In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 7th edn. New York: McGraw-Hill, 1995; 2103-42
2. Deacon AC, Elder GH. Front line tests for the investigation of suspected porphyria. J Clin Pathol 2001; 54: 500-7
3. Hindmarsh JT. The porphyrias, appropriate test selection. Clin Chim Acta 2003; 333: 203-7
4. Jones MA, Thientanavanich P, Anderson MD, Lash TD. Comparison of two assay methods for activities of uroporphyrinogen decarboxylase and coproporphyrinogen oxidase. J Biochem Biophys Meth 2003; 55: 241-9
5. Mendez M, Sorkin L, Rossetti MV, et al. Familial Porphyria Cutanea Tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common haemochromatosis alleles. Am J Hum Genet 1998; 63: 1363-75
6. The European Porphyria Initiative. http://www.porphyria-europe. com (accessed March 2005)
7. Meissner PN, Dailey TA, Hift RJ, et al. A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria. Nat Genet 1996; 13: 95-7
8. Sturrock ED, Meissner PN, Maeder DL, Kirsch RE. Uroporphyrinogen decarboxylase and protoporphyrinogen oxidase in dual porphyria. SAMJ 1989; 76: 405-8
9. Seig I, Bhutani LK, Doss MO. Dual porphyria of coexisting variegata and cutanea tarda. Eur J Clin Chem Biochem 1995; 33: 405-10
10. Doss MO. Dual porphyria in double heterozygotes with porphobilinogen deaminase and uroporphyrinogen decarboxylase deficiencies. Clin Genet 1989; 35: 146-51
11. Ratnaike S, Blake D. The diagnosis and follow-up of porphyria. Pathology 1995; 27: 142-53
12. Piepkorn NW, Hamernyik P, Labbe RF. Modified erythrocyte uroporphyrinogen 1 synthase assay, and its clinical interpretation. Clin Chem 1978; 24: 1751-4
13. Puy H, Deybach JC, Lamoril J, et al. Molecular epidemiology and diagnosis of PBG Deaminase gene defects in acute intermittent porphyria. Am J Hum Genet 1997; 60: 1373-83
14. ELXR: Exon Locator & eXtractor for Resequencing. www.exon. swmed.edu (accessed January 2005)
15. Lundin G, Hashemi J, Floderus Y, et al. Four mutations in the porphobilinogen deaminase gene in patients with acute intermittent porphyria. J Med Genet 1995; 32: 979-81
16. Phillips JD, Parker TL, Schubert HL, Whitby FG, Hill CP, Kushner JP. Functional consequences of naturally occurring mutations in human uroporphyrinogen decarboxylase. Blood 2001; 98: 3179-85
17. Lambrecht RW, Bonkovsky HL. Haemochromatosis and porphyria. Semin Gastrointest Dis 2002; 13: 109-19
18. Burt MJ, George PM, Upton JD, et al. The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 1998; 43: 830-6